Mechanisms of IhERG/IKr Modulation by α1-Adrenoceptors in HEK293 Cells and Cardiac Myocytes

Cell Physiol Biochem. 2016;40(6):1261-1273. doi: 10.1159/000453180. Epub 2016 Dec 19.

Abstract

Background: The rapid delayed rectifier K+ current (IKr), carried by the hERG protein, is one of the main repolarising currents in the human heart and a reduction of this current increases the risk of ventricular fibrillation. α1-adrenoceptors (α1-AR) activation reduces IKr but, despite the clear relationship between an increase in the sympathetic tone and arrhythmias, the mechanisms underlying the α1-AR regulation of the hERG channel are controversial. Thus, we aimed to investigate the mechanisms by which α1-AR stimulation regulates IKr.

Methods: α1-adrenoceptors, hERG channels, auxiliary subunits minK and MIRP1, the non PIP2-interacting mutant D-hERG (with a deletion of the 883-894 amino acids) in the C-terminal and the non PKC-phosphorylable mutant N-terminal truncated-hERG (NTK-hERG) were transfected in HEK293 cells. Cell membranes were extracted by centrifugation and the different proteins were visualized by Western blot. Potassium currents were recorded by the patch-clamp technique. IKr was recorded in isolated feline cardiac myocytes.

Results: Activation of the α1-AR reduces the amplitude of IhERG and IKr through a positive shift in the activation half voltage, which reduces the channel availability at physiological membrane potentials. The intracellular pathway connecting the α1-AR to the hERG channel in HEK293 cells includes activation of the Gαq protein, PLC activation and PIP2 hydrolysis, activation of PKC and direct phosphorylation of the hERG channel N-terminal. The PKC-mediated IKr channel phosphorylation and subsequent IKr reduction after α1-AR stimulation was corroborated in feline cardiac myocytes.

Conclusions: These findings clarify the link between sympathetic nervous system hyperactivity and IKr reduction, one of the best characterized causes of torsades de pointes and ventricular fibrillation.

MeSH terms

  • Animals
  • Cats
  • Enzyme Activation / drug effects
  • Ether-A-Go-Go Potassium Channels / metabolism*
  • HEK293 Cells
  • Humans
  • Ion Channel Gating* / drug effects
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / enzymology
  • Myocytes, Cardiac / metabolism*
  • Phenylephrine / pharmacology
  • Phosphatidylinositol 4,5-Diphosphate / metabolism
  • Phosphorylation / drug effects
  • Potassium Channels, Voltage-Gated / metabolism
  • Protein Kinase C / metabolism
  • Protein Serine-Threonine Kinases / metabolism
  • Receptors, Adrenergic, alpha-1 / metabolism*
  • Signal Transduction / drug effects
  • Type C Phospholipases / metabolism

Substances

  • Ether-A-Go-Go Potassium Channels
  • KCNE2 protein, human
  • KCNH1 protein, human
  • Phosphatidylinositol 4,5-Diphosphate
  • Potassium Channels, Voltage-Gated
  • Receptors, Adrenergic, alpha-1
  • Phenylephrine
  • MINK1 protein, human
  • Protein Serine-Threonine Kinases
  • Protein Kinase C
  • Type C Phospholipases